Poor ovarian response. other mathernal disorders predominantly related to pregnancy
Conditions
Interventions
Intervention 1: Patients were pretreated for 21 days with OCP. Busereline (80 µg s.c.) is administered from day 2 or 3 of cycle. Gonal F at dose of 225-450 IU/day i.m is started according to the patie
Treatment - Drugs
Patients were pretreated for 21 days with OCP. Busereline (80 µg s.c.) is administered from day 2 or 3 of cycle. Gonal F at dose of 225-450 IU/day i.m is started according to the patients' situation a
Patients were pretreated for 21 days with OCP. Busereline (500 µg s.c.) is administered from day 2 or 3 of cycle. Gonal F at dose of 225-450 IU/day i.m is started according to the patients' situation
Sponsors
Royan Institute
Eligibility
Sex/Gender
Female
Age
No minimum to 42 Years
Inclusion criteria
Inclusion criteria: history of oocyte number less than 3 (in previous cycle) 3. number of antral follicle less than 5 in previous cycle 4. age more than 38 years 5. FSH>12 on day 2 or 3 6. Ovarian Volume 3 cubic centimeter Exclusion Criteria: Male factor (azospermi), Myoma = 6cm, single ovary, tumor or cyst with size more than 13mm, age more than 42
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: ß-hCG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cycle cancellation rates. Timepoint: 6 weeks. Method of measurement: Number of sac. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghaffari
Royan Institute
Outcome results
None listed